Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Berg Johannes Lorenz |
** = Publikationen gelistet in SCI/SSCI/Pubmed
2023
Originalarbeit (Zeitschrift)
** Jandl, K; Berg, JL; Birnhuber, A; Fliesser, E; Borek, I; Seeliger, B; David, S; Schmidt, JJ; Gorkiewicz, G; Zacharias, M; Welte, T; Olschewski, H; Heinemann, A; Wygrecka, M; Kwapiszewska, G
Basement membrane product, endostatin, as a link between inflammation, coagulation and vascular permeability in COVID-19 and non-COVID-19 acute respiratory distress syndrome.
Front Immunol. 2023; 14: 1188079
Doi: 10.3389/fimmu.2023.1188079
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Übersichtsarbeit
** Fliesser, E; Lins, T; Berg, JL; Kolb, M; Kwapiszewska, G
The endothelium in lung fibrosis: a core signaling hub in disease pathogenesis?
AM J PHYSIOL-CELL PH. 2023; 325(1): C2-C16.
Doi: 10.1152/ajpcell.00097.2023
Web of Science
PubMed
FullText
FullText_MUG
2021
Originalarbeit (Zeitschrift)
** Berg, JL; Perfler, B; Hatzl, S; Mayer, MC; Wurm, S; Uhl, B; Reinisch, A; Klymiuk, I; Tierling, S; Pregartner, G; Bachmaier, G; Berghold, A; Geissler, K; Pichler, M; Hoefler, G; Strobl, H; Wölfler, A; Sill, H; Zebisch, A
Micro-RNA-125a mediates the effects of hypomethylating agents in chronic myelomonocytic leukemia.
Clin Epigenetics. 2021; 13(1): 1-1.
Doi: 10.1186/s13148-020-00979-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Berg, JL; Perfler, B; Hatzl, S; Uhl, B; Reinisch, A; Pregartner, G; Berghold, A; Penz, T; Schuster, M; Geissler, K; Prokesch, A; Müller-Tidow, C; Hoefler, G; Kashofer, K; Wölfler, A; Sill, H; Caraffini, V; Zebisch, A
EZH2 inactivation in RAS-driven myeloid neoplasms hyperactivates RAS-signaling and increases MEK inhibitor sensitivity.
Leukemia. 2021; 35(5):1521-1526
Doi: 10.1038/s41375-021-01161-0
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Kurzbericht/Letter
** Mayer, MC; Berg, JL; Perfler, B; Hatzl, S; Herzog, SA; Bachmaier, G; Berghold, A; Reinisch, A; Wölfler, A; Sill, H; Zebisch, A
miR-23a mediates resistance to hypomethylating agents in myeloid neoplasms.
ANN HEMATOL. 2021; 100(11): 2845-2847.
Doi: 10.1007/s00277-021-04598-6
Web of Science
PubMed
FullText
FullText_MUG
2018
Originalarbeit (Zeitschrift)
** Caraffini, V; Perfler, B; Berg, JL; Uhl, B; Schauer, S; Kashofer, K; Ghaffari-Tabrizi-Wizsy, N; Strobl, H; Wölfler, A; Hoefler, G; Sill, H; Zebisch, A
Loss of RKIP is a frequent event in myeloid sarcoma and promotes leukemic tissue infiltration.
Blood. 2018; 131(7): 826-830.
Doi: 10.1182/blood-2017-09-804906
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG